Interventional Oncology Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Interventional oncology is a field of treatment that focuses on the treatment of cancers using minimally invasive procedures driven by image guidance. Interventional oncology is gaining a lot of popularity in the treatment of cancer because minimally invasive procedures are less painful and less risky than conventional operations. Market players develops products for interventional radiologists that specialize in treating patients with oncological indications. Rising to the challenge of creating innovative treatments for patients, market players bringing a complete range of interventional oncology products that focus on Access, Loco-regional treatments and Endovascular embolization.

MARKET DYNAMICS

Factors driving the growth of the interventional oncology device market are the growing Incidence rate of cancers worldwide, coupled with high preference for minimally invasive procedures. However, financial burden on the companies due to product recall is expected to hamper the growth of the market. Moreover, increasing funding from the government in the Developed Countries and favorable reimbursement scenario for interventional oncology treatment is anticipated to boost the market growth.

MARKET SCOPE

The "Interventional Oncology Device Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of interventional oncology device market with detailed market segmentation by product type, procedure, and cancer type. The interventional oncology device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in interventional oncology device market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The interventional oncology device market is segmented on the basis of product type, procedure, and cancer type. Based on product type, the market is segmented as ablation devices, embolization device, and support devices. Ablation devices sub segmented as microwave ablation, radiofrequency ablation, cryoablation, cryoablation, and others. Embolization device sub segmented as radioembolic agents and non-radioactive embolic agents. Support devices sub segmented as microcatheters and guidewires. On the basis of procedure, the market is categorized as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), transcatheter arterial embolization (TAE) or bland embolization. On the basis of cancer type, the market is categorized as lung cancer, breast cancer, liver cancer, kidney cancer, prostate cancer, and others

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the interventional oncology device market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The interventional oncology device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting interventional oncology device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the interventional oncology device market in these regions.

MARKET PLAYERS

The report covers key developments in the interventional oncology device market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from interventional oncology device market are anticipated to have lucrative growth opportunities in the future with the rising demand for interventional oncology device in the global market. Below mentioned is the list of few companies engaged in the interventional oncology device market.

The report also includes the profiles of key players in interventional oncology device market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Boston Scientific Corporation
  
•   Medtronic plc
  
•   Merit Medical Systems Inc.
  
•   Terumo Corporation
  
•   HealthTronics Inc.
  
•   Medtronic
  
•   Sirtex Medical Limited
  
•   AngioDynamics
  
•   Johnson & Johnson Services, Inc.
  
•   Teleflex Incorporated
  
•   Cook
  
•   Varian Medical Systems, Inc.
  
•   Eckert & Ziegler BEBIG
  
•   3M
  
•   MedWaves, Inc.
  
•   IMBIOTECHNOLOGIES LTD.
  
•   Trod Medical
  
•   Smith Medical
  
•   NEWTECH MEDICAL DEVICES
  
•   IceCure Medical Ltd
  
•   Accuray Incorporated
  
•   Sanarus
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Interventional Oncology Device Report Scope